Side-by-side comparison of AI visibility scores, market position, and capabilities
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
AI market research platform for hedge funds and PE firms with source-cited analysis integrating external data with private client data; $500K YC-backed competing with AlphaSense for institutional intelligence.
AlphaWatch AI is a New York-based market research intelligence platform that uses proprietary large language models and specialized embedding models to deliver AI-powered analysis for institutional investors and corporate strategy teams — providing hedge funds, private equity firms, and Fortune 500 companies with credible, source-cited market intelligence that synthesizes external research sources with clients' protected private data for superior investment and competitive analysis. Founded in 2023 and backed by Y Combinator and Amino Capital with $500,000 in seed funding, AlphaWatch operates with a 4-6 person team.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.